FEATURES OF COL1A1 EXPRESSION IN BREAST CANCER TISSUE OF YOUNG PATIENTS

Authors

  • V. Chekhun R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
  • O. Mushii R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
  • T. Zadvornyi R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
  • T. Borikun R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
  • О. Martyniuk R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
  • E. Kashuba R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
  • A. Kryzhanivska Ivano-Frankivsk National Medical University, Department of Oncology, Ivano-Frankivsk, Ukraine.
  • A. Andriiv Ivano-Frankivsk National Medical University, Department of Oncology, Ivano-Frankivsk, Ukraine.
  • I. Diakiv Ivano-Frankivsk National Medical University, Department of Oncology, Ivano-Frankivsk, Ukraine.
  • N. Lukianova R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.

DOI:

https://doi.org/10.15407/exp-oncology.2023.03.351

Keywords:

breast cancer, collagen, COL1A1, young patients

Abstract

Background. In the last decades, the incidence of breast cancer (BCa) in young women has been increasing steadily. The quantitative indicators of expression of collagen, which play important role in stromal microenvironment, and their association with the age and survival rates of BCa patients have not been yet definitively clarified. Aim. To investigate the relationship between the COL1A1 gene expression at the mRNA and protein levels in BCa tissue and the clinicopatological features and survival rates of BCa patients of different age groups. Materials and Methods. The study was conducted on the clinical material of 50 patients with stage I—III BCa. COL1A1 gene expression at the mRNA and protein levels in BCa tissue were studied using the real-time PCR and immunohistochemical methods, as well as the bioinformatic analysis (UALCAN and Kaplan — Meier Plotter databases). Results. The bioinformatic analysis showed that BCa tissue is characterized by 6.0 times (p < 0.05) higher level of COL1A1 mRNA compared to normal breast tissue. The correlation of COL1A1 expression at the mRNA and protein levels with the molecular subtype of neoplasms was demonstrated. According to Kaplan — Meier Plotter database, a low level of expression of COL1A1 protein level in BCa tissue is associated with lower rates of relapse-free survival of patients. The ex vivo study of the clinical material revealed a decrease in COL1A1 protein expression in tumor tissue of young patients with BCa of T3 category (p < 0.0374), low differentiation grade (p < 0.0163) and basal molecular subtype (p < 0.0001). A correlation between the expression of COL1A1 at the mRNA and protein levels and the expression status of estrogen receptors (p < 0.0001) and progesterone receptors (p < 0.0040) was established. The relapse-free 3-year survival rate of young BCa patients is significantly lower in the presence of a low COL1A1 optical density index in the tumor tissue. Conclusions. The identified relationship between COL1A1 expression and such indicators of BCa malignancy as tumor size, differentiation grade, molecular subtype, receptor status, and the recurrencefree survival of patients indicates the prospects of its use to predict the aggressiveness of the BCa course in young patients.

References

Chekhun V, Martynyuk О, Lukianova Y, et al. Features of breast cancer in patients of young age: search for diagnosis optimization and personalized treatment. Exp Oncol. 2023;45(2):139-150. https://doi.org/10.15407/ exp-oncology.2023.02.139

Fedorenko Z, Soumkina O, Gorokh Ye, et al. Cancer in Ukraine 2020-2021: Incidence, mortality, prevalence and other relevant statistics. Bull Nat Cancer Registry Ukr. 2022; 23: 89.

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and morta- lity worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. https://doi.org/10.3322/ caac.21660

Mittal S, Brown NJ, Holen I. The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Rev Mol Diagn. 2018;18(3):227-243. https://doi.org/10.1080/14737159.2018.1 439382

Lukianova N, Mushii O, Borikun T, et al. Pattern of MMP2 and MMP9 expression depends on breast cancer patients' age. Exp Oncol. 2023;45(1):17-27. https://doi.org/10.15407/exp-oncology.2023.01.017

Vangangelt KMH, Kramer CJH, Bastiaannet E, et al. The intra-tumoural stroma in patients with breast cancer increases with age. Breast Cancer Res Treat. 2020;179(1):37-45. https://doi.org/10.1007/s10549-019-05422-6

Lukianova N, Zadvornyi T, Mushii О, et al. Evaluation of diagnostic algorithm based on collagen organization parameters for breast tumors. Exp Oncol. 2022;44(4):281-286. https://doi.org/10.32471/exp-oncology.2312-8852. vol-44-no-4.19137

Sorushanova A, Delgado LM, Wu Z, et al. The collagen suprafamily: from biosynthesis to advanced biomaterial development. Adv Mater. 2019;31(1):e1801651. https://doi.org/10.1002/adma.201801651

Shi R, Zhang Z, Zhu A, et al. Targeting type I collagen for cancer treatment. Int J Cancer. 2022;151(5):665-683. https://doi.org/10.1002/ijc.33985

Provenzano PP, Eliceiri KW, Campbell JM, et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4(1):38. https://doi.org/10.1186/1741-7015-4-38

Schrader J, Gordon-Walker TT, Aucott RL, et al. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology. 2011;53(4):1192-1205. https://doi.org/10.1002/hep.24108

Guiu S, Michiels S, André F, et al. Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol. 2012;23(12):2997-3006. https://doi.org/10.1093/annonc/mds586

Seyed Jafari SM, Hunger RE. IHC optical density score: a new practical method for quantitative immunohistochemistry image analysis. Appl Immunohistochem Mol Morphol. 2017;25(1):e12-e13. https://doi.org/10.1097/PAI.0000000000000370

OriGene Technologies Inc. Collagen I (COL1A1) human qPCR primer pair (NM_000088) [Internet]. Origene. com. [cited 2023 Oct 23]. Available from: https://www.origene.com/catalog/gene-expression/qpcr-primer-pairs/ hp200074/collagen-i-col1a1-human-qpcr-primer-pair-nm_000088.

Guo Q, Sun D, Barrett AS, et al. Mammary collagen is under reproductive control with implications for breast cancer. Matrix Biol. 2022;105:104-126. https://doi.org/10.1016/j.matbio.2021.10.006

Checka CM, Chun JE, Schnabel FR, et al. The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol. 2012;198(3):W292-W295. https://doi.org/10.2214/AJR.10.6049

Jiang Y, Wang B, Li JK, et al. Collagen fiber features and COL1A1: are they associated with elastic parameters in breast lesions, and can COL1A1 predict axillary lymph node metastasis? BMC Cancer. 2022;22(1):1004. https://doi.org/10.1186/s12885-022-10092-7

Kim SH, Lee HY, Jung SP, et al. Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines. Oncol Lett. 2014;8(2):507-512. https://doi.org/10.3892/ol.2014.2199

Antoni S, Sasco AJ, dos Santos Silva I, McCormack V. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat. 2013;137(2):337-347. doi:10.1007/s10549-012-2362-4

Barcus CE, O'Leary KA, Brockman JL, et al. Elevated collagen-I augments tumor progressive signals, intravasa- tion and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells. Breast Cancer Res. 2017;19(1):9. https://doi.org/10.1186/s13058-017-0801-1

Liu J, Shen JX, Wu HT, et al. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med. 2018;25(139):211-223.

Morikawa A, Ohara N, Xu Q, et al. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloprotein- ase inducer. Hum Reprod. 2008;23(4):944-951. https://doi.org/10.1093/humrep/den025

Tian Y, Guida JL, Koka H, et al. Quantitative mammographic density measurements and molecular subtypes in chinese women with breast cancer. JNCI Cancer Spectr. 2020;5(1):pkaa092. https://doi.org/10.1093/jncics/pkaa092

Shaikh AJ, Mullooly M, Sayed S, et al. Mammographic breast density and breast cancer molecular subtypes: the kenyan-african aspect. Biomed Res Int. 2018;2018:6026315. https://doi.org/10.1155/2018/6026315

Downloads

Published

28.12.2023

How to Cite

Chekhun, V., Mushii, O., Zadvornyi, T., Borikun, T., Martyniuk О., Kashuba, E., … Lukianova, N. (2023). FEATURES OF COL1A1 EXPRESSION IN BREAST CANCER TISSUE OF YOUNG PATIENTS. Experimental Oncology, 45(3), 351–363. https://doi.org/10.15407/exp-oncology.2023.03.351

Issue

Section

Original contributions

Most read articles by the same author(s)

1 2 > >>